Publication Analytics of the Microbiome Landscape, 2011-2020
September 16, 2021 04:13 ET
|
Research and Markets
Dublin, Sept. 16, 2021 (GLOBE NEWSWIRE) -- The "2021 Publication Analytics of the Microbiome Landscape" report has been added to ResearchAndMarkets.com's offering. Publication of scientific papers...
Global Microbiome Landscape Market Study 2021: Growing Research and Skyrocketing Venture Funding
August 30, 2021 05:23 ET
|
Research and Markets
Dublin, Aug. 30, 2021 (GLOBE NEWSWIRE) -- The "2021 Analytics of the Microbiome Landscape" report has been added to ResearchAndMarkets.com's offering. Catalyzed by growing research and skyrocketing...
Microbiome Landscape Startup Funding Analytics Report 2021: Startup Activity 2015-2020 & Investment Trends
August 25, 2021 10:23 ET
|
Research and Markets
Dublin, Aug. 25, 2021 (GLOBE NEWSWIRE) -- The "2021 Startup Funding Analytics of the Microbiome Landscape" report has been added to ResearchAndMarkets.com's offering. Like other avenues in the...
Microbiome Landscape Grant Analytics Report 2021: Funding Dropped from $1.9B in 2019 to $1.1B in 2020
August 24, 2021 03:23 ET
|
Research and Markets
Dublin, Aug. 24, 2021 (GLOBE NEWSWIRE) -- The "2021 Grant Analytics of the Microbiome Landscape" report has been added to ResearchAndMarkets.com's offering. Several pioneering studies from 2006...
World Microbiome Landscape Clinical Trial Analytics Report 2021: Top 10 Sponsors and Top 10 Companies with Most Ongoing Microbiome Trials
August 24, 2021 03:18 ET
|
Research and Markets
Dublin, Aug. 24, 2021 (GLOBE NEWSWIRE) -- The "2021 Clinical Trial Analytics of the Microbiome Landscape" report has been added to ResearchAndMarkets.com's offering. The number of ongoing clinical...
Summit Therapeutics Provides Update on Ri-CoDIFy Trials
August 11, 2021 08:00 ET
|
Summit Therapeutics Inc.
Cambridge, Massachusetts, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Based on a thorough review of the design and enrollment status of two ongoing blinded Phase III Ri-CoDIFy trials, Summit Therapeutics...
Global Microbiome Markets 2021-2030: Fecal Microbiota Transplantation (FMT), Drugs, Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers
July 07, 2021 05:03 ET
|
Research and Markets
Dublin, July 07, 2021 (GLOBE NEWSWIRE) -- The "Microbiome Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's...
Summit Therapeutics to Present Breakthrough Research Updates at the 31st Annual ECCMID Conference, including a Top-Rated ePoster
July 01, 2021 08:00 ET
|
Summit Therapeutics Inc.
Cambridge, MA, July 01, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (the “Company”) today announced that members of our scientific team will present breakthrough research...
Derm-Biome Pharmaceuticals, Inc. files a US provisional patent for a new generation of natural product-based derivatives and their uses for treating chronic inflammatory skin conditions
June 29, 2021 09:30 ET
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, June 29, 2021 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a private Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is...
Global Microbiome Markets Report 2021: Market is Expected to Reach $940 Million in 2025 - Forecasts to 2030
June 17, 2021 07:08 ET
|
Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Microbiome Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. Microbiome Global...